May 16 (Reuters) - Kanchi Karpooram Ltd KCHI.BO : * MARCH QUARTER PROFIT 46.5 MILLION RUPEES VERSUS PROFIT 3.4 MILLION RUPEES YEAR ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The October-December quarter (Q3) of FY25 record deal-intake of $1.68 billion (up 29 per cent quarter-on-quarter or QoQ) could aid growth in Q4FY25 ...

Aug 13 (Reuters) - Kanchi Karpooram Ltd KCHI.BO : * JUNE QUARTER PROFIT 82.7 MILLION RUPEES VERSUS 100.4 MILLION RUPEES YEAR AGO * JUNE QUARTER INCOME FROM OPERATIONS 554.9 MILLION ...

Gensol Engineering Limited (BSE: 542851, NSE: GENSOL), a leading player in India’s renewable energy sector, has signed a non-binding Term Sheet for an INR 350 crore strategic transaction ...

Outcome of the Board meeting held on 29th May, 2024- Considered and approved the accounts and audited financial results (standalone and consolidated) for the FY 2023-24 Kanchi Karpooram Board Meeting ...

Pursuant to Reg 30 & 47 of SEBI (LODR) the Company has published the un-audited financial results for the quarter and nine months ended 31st December 2024 in the Trinity Mirror and Makkal Kural on ...

Emcure Pharmaceuticals received two observations from the USFDA after an inspection of its Pune-based API manufacturing facility. The company is addressing the observations and will respond to the ...

Kanchi Karpooram - Considered And Approved The Un-Audited (Standalone And Consolidated) Financial Results For The Quarter And The Board in their meeting held on 13th February 2025, interalia ...